home / stock / pmvp / pmvp quote
Last: | $1.50 |
---|---|
Change Percent: | 0.0% |
Open: | $1.56 |
Close: | $1.50 |
High: | $1.56 |
Low: | $1.48 |
Volume: | 386,837 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.5 | $1.56 | $1.5 | $1.56 | $1.48 | 386,837 | 07-05-2024 |
$1.56 | $1.58 | $1.56 | $1.6 | $1.55 | 151,230 | 07-04-2024 |
$1.56 | $1.58 | $1.56 | $1.6 | $1.55 | 151,230 | 07-03-2024 |
$1.57 | $1.57 | $1.57 | $1.645 | $1.5587 | 361,052 | 07-02-2024 |
$1.58 | $1.61 | $1.58 | $1.64 | $1.565 | 499,291 | 07-01-2024 |
$1.62 | $1.68 | $1.62 | $1.695 | $1.57 | 5,877,576 | 06-28-2024 |
$1.66 | $1.66 | $1.66 | $1.71 | $1.61 | 339,353 | 06-27-2024 |
$1.66 | $1.68 | $1.66 | $1.71 | $1.62 | 314,294 | 06-26-2024 |
$1.68 | $1.69 | $1.68 | $1.695 | $1.66 | 380,423 | 06-25-2024 |
$1.69 | $1.61 | $1.69 | $1.69 | $1.61 | 317,560 | 06-24-2024 |
$1.615 | $1.57 | $1.615 | $1.63 | $1.57 | 392,422 | 06-21-2024 |
$1.58 | $1.61 | $1.58 | $1.635 | $1.56 | 442,877 | 06-20-2024 |
$1.61 | $1.65 | $1.61 | $1.66 | $1.605 | 256,617 | 06-19-2024 |
$1.61 | $1.65 | $1.61 | $1.66 | $1.605 | 256,617 | 06-18-2024 |
$1.65 | $1.66 | $1.65 | $1.68 | $1.6025 | 216,265 | 06-17-2024 |
$1.67 | $1.71 | $1.67 | $1.73 | $1.64 | 400,223 | 06-14-2024 |
$1.74 | $1.78 | $1.74 | $1.78 | $1.68 | 515,398 | 06-13-2024 |
$1.77 | $1.75 | $1.77 | $1.83 | $1.68 | 532,574 | 06-12-2024 |
$1.73 | $1.7 | $1.73 | $1.73 | $1.675 | 273,342 | 06-11-2024 |
$1.7 | $1.66 | $1.7 | $1.8 | $1.62 | 840,124 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
PMV Pharmaceuticals Inc. Company Name:
PMVP Stock Symbol:
NASDAQ Market:
PMV Pharmaceuticals Inc. Website:
PRINCETON, N.J., May 30, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Off...
BOSTON and PRINCETON, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ: PMVP; “PMV Pharma”) today announced a partnership to develop Foundation Medicine’s tissue-based comprehensive genomic profiling test, FoundationOn...
2024-05-13 08:30:02 ET Craig-Hallum analyst issues BUY recommendation for PMVP on May 13, 2024 07:30AM ET. PMVP was trading at $2.04 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 3 - Buy recommendations...